The underlying purpose of this commentary and position paper is to achieve evidence-based recommendations on prevention of work-related musculoskeletal disorders (MSDs). Such prevention can take different forms (primary, secondary and tertiary), occur at different levels (i.e. in a clinical setting, at the workplace, at national level) and involve several types of activities. Members of the Scientific Committee (SC) on MSDs of the International Commission on Occupational Health (ICOH) and other interested scientists and members of the public recently discussed the scientific and clinical future of prevention of (work-related) MSDs during five round-table sessions at two ICOH conferences (in Cape Town, South Africa, in 2009, and in Angers, France, in 2010). Approximately 50 researchers participated in each of the sessions. More specifically, the sessions aimed to discuss new developments since 1996 in measures and classification systems used both in research and in practice, and agree on future needs in the field.

This study aimed to evaluate the risk of musculoskeletal disorders to the hand-wrist system. The American Conference of Governmental Industrial Hygienists (ACGIH) proposed threshold limit values (TLV©) based on hand activity level (HAL) and normalized peak force (PF). We validated ACGIH TLV© in OCTOPUS, a large cohort study on carpal tunnel syndrome (CTS). Industrial and service workers were followed from 2000-2003. We classified subjects with respect to action limit (AL) and TLV. Case definitions were: (i) self-reported symptoms; and (ii) combination of symptoms and positive nerve conduction studies. Poisson regression models including age, gender, body mass index, and presence of predisposing pathologies were conducted to estimate incidence rate ratios (IRR) of CTS. There were 4097 eligible workers. Of these, 236 (5.8%) were non-responders, 2194 (53.6%) had a complete follow-up, 728 (17.8%) were lost after intermediate assessment, and 939 (22.9%) were lost after baseline. Among the 3860 subjects with complete information at baseline, 2599 (67.3%) were women [mean age 38.1 [standard deviation (SD) 9.5] years; mean body mass index (BMI) 23.8 (SD 3.9) kg/m2]. ACGIH TLV© classification predicted both CTS symptoms [IRR between AL and TLV 2.43 [95% confidence interval (95% CI) 1.77-3.33]; above TLV 3.32 (95% CI 2.34-4.72)] and CTS confirmed by nerve conduction studies [IRR between AL and TLV 1.95 (95% CI 1.21-3.16); above TLV 2.70 (95% CI 1.48-4.91)]. We found a dose-response relationship between ACGIH TLV© classification and risk of CTS. The increased risk observed for workers exposed between AL and TLV suggests that the current AL and TLV might not be sufficiently protective.

Purpose of review: To assess the methodological approach to epidemiological research on musculoskeletal disorders and diseases based on current scientific position. Recent findings: Musculoskeletal disorders (MSDs) are the leading contributor to disability worldwide, with low back pain being the single primary cause of disability in most of the countries in the world. However, there is still a lack of comparable data because of different case definitions, which are split according to body region/specific disease. Traditionally related to physical overload, current evidence shows that MSDs might result from hereditary, congenital, or acquired pathologic processes. The term work-related MSDs (WRMSDs) is commonly used when reasonable association with occupational physical and psychosocial conditions is recognized. Summary: After decades of research, we still find gaps in the literature on WRMSDs, especially concerning diagnostic criteria, workplace exposure assessment, and compensation. The impact of new technologies, flexible/remote work, new forms of employment, changes in the working environment as well as of sedentary work, is now emerging. Therefore, conventional forms of epidemiological research in MSD prevention, needs to be adapted. Together with ongoing harmonization policies, new perspectives for exposure and clinical assessment are required, as well as strategies for monitoring large cohorts of individuals along the working day and the lifespan. There is a need for new approaches for planning and promoting interventions to prevent MSDs and to support vulnerable groups.